Aegerion Pharmaceuticals, Inc. (AEGR) Tops Q1 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Aegerion (AEGR) Q1 Juxtapid Sales 'Surprisingly Weak', Jefferies Says
May 7, 2014 9:00 AM EDTJefferies analyst Eun K. Yang, Ph.D lowered his price target on Buy-rated Aegerion Pharmaceuticals (NASDAQ: AEGR) to $61.00 (from $80.00) following 'surprisingly' weak Q1 Juxtapid sales.
Yang comments, "While AEGR is confident of meeting its ~5% lowered guidance ($180M-$200M), surprisingly weak 1Q14 Juxtapid... More
Aegerion (AEGR) PT Lowered to $70 at Deutsche Bank Due to Slow Patient Growth
May 7, 2014 8:37 AM EDTDeutsche Bank maintained a Buy rating on Aegerion Pharmaceuticals (NASDAQ: AEGR) an reduced its price target to $70.00 (from $115.00). Analyst Robyn Karnauskas expressed caution due to slow patient growth.
"Juxtapid 1Q revenues at $27M were lower than consensus at $33.6M primarily due to lower sales in ex-US.... More
Cowen Downgrades Aegerion Pharmaceuticals (AEGR) to Market Perform
May 7, 2014 7:27 AM EDTCowen downgraded Aegerion Pharmaceuticals (NASDAQ: AEGR) from Outperform to Market Perform with a price target of $36.00 (from $85).
For an analyst ratings summary and ratings history on Aegerion Pharmaceuticals click here. For more ratings news on Aegerion Pharmaceuticals click here.
Shares of Aegerion Pharmaceuticals closed at $44.16 yesterday.
... More